2015
DOI: 10.1016/j.patbio.2015.07.005
|View full text |Cite
|
Sign up to set email alerts
|

What common biomarkers characterize a triple-negative profile in breast cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 94 publications
0
9
0
Order By: Relevance
“…Several predictive biomarkers in TNBC, including the epidermal growth factor receptor (EGFR), androgen receptor and the adhesion molecules CD24 and CD44, have been investigated in recent years (2831). To the best of the authors' knowledge, the prognostic value of the expression levels of CRT and EVI-1 in TNBC is unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Several predictive biomarkers in TNBC, including the epidermal growth factor receptor (EGFR), androgen receptor and the adhesion molecules CD24 and CD44, have been investigated in recent years (2831). To the best of the authors' knowledge, the prognostic value of the expression levels of CRT and EVI-1 in TNBC is unknown.…”
Section: Introductionmentioning
confidence: 99%
“…An earlier case study on Korean women ( n = 1026) indicated that the mean age of breast cancer diagnosis was 46.8 years with 14.4 and 26.3 as the age of menarche and first parturition ( Kang et al, 2014 ). However, other studies indicated that 2–20% of women diagnosed with breast cancer were under the age of 35 years with tumors that present aggressive biological behavior resulting in mortality and metastasis ( Kallel et al, 2015 ). Moreover, women’s reproductive life, precocious menarche, nulliparity, age of first gestation over 30 years, oral contraceptives, late menopause, and hormone replacement therapy are also well established in relation to breast cancer development ( Thuler, 2003 ; Pinho and Coutinho, 2007 ; Brasil, 2008 , 2009 ).…”
Section: Resultsmentioning
confidence: 99%
“…The age in association with hormone receptors status, family history, and genetic aspects may have implications on cancer therapies ( Peto and Mack, 2000 ; Pinho and Coutinho, 2007 ; Lizarraga et al, 2013 ). Previous studies have shown that young women with triple negative breast tumors have worst prognosis regarding recurrence and mortality ( Kallel et al, 2015 ; Reviriego et al, 2016 ). Endocrine factors/reproductive history is mainly related to estrogen stimulation whether endogenous or exogenous, pregnancy after 30 years, nulliparity, use of oral contraceptives (estrogen–progesterone), and postmenopausal hormone replacement therapy (estrogen–progesterone) are all associated with breast cancer incidence ( International Agency for Research on Cancer [IARC], 2015 ; World Health Organization [WHO], 2015 ).…”
Section: Resultsmentioning
confidence: 99%
“…Up-regulation: Micro-RNAs (miR-10b, miR-341, miR-195) (Bedreag et al, 2015); ER, PR, CA15-3, HER2 (Silva, 2015); EGFR, TNBC, HER1/ErbB1, HER2/new/ErbB2, HER3/ ErbB3, and HER4/ErbB4, TNCs, Bcl-2, adhesion molecule (CD44/CD24), BRCA1/A2, p53, p63, p53siRNA gene, p16INK4a, cytokeratins 5, 14, and 17 (Kallel et al, 2015).…”
Section: Breast Cancermentioning
confidence: 99%